Incyte
Price & Volume
Stats
See moreOpen | $120.45 |
Previous Close | $117.59 |
Day Range | $118.05-$121.28 |
52W Range | $89.25-$132.60 |
Market Cap | $24.4B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $6B |
Revenue Growth (YoY) | 14% |
Gross Profit (12 Mos) | $3.3B |
Diluted EPS | $1.96 |
News
See moreYahoo Finance • 10 days ago
Genmab, Incyte team up to develop experimental colorectal cancer treatment
Yahoo Finance • 11 days ago
Does Genmab Trial Deal Change The Bull Case For Incyte (INCY)?
Yahoo Finance • 11 days ago
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Yahoo Finance • 11 days ago
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
About
CEO | Mr. William J. Meury |
CFO | Mr. Suketu P. Upadhyay |
Address | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,844 |